Epigral Limited (NSE: EPIGRAL)

Market Cap	76.55B
Revenue (ttm)	21.26B
Net Income (ttm)	2.50B
Shares Out	41.55M
EPS (ttm)	60.23
PE Ratio	30.59
Forward PE	23.34
Dividend	5.00 (0.27%)
Ex-Dividend Date	Jul 2, 2024

Volume	57,727
Open	1,868.00
Previous Close	1,863.55
Day's Range	1,825.80 - 1,884.90
52-Week Range	872.10 - 2,026.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Epigral

Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda, chlorine, hydrogen, and caustic potash products. It also engages in the trading of agrochemical products. It serves various sectors, including CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and dete...

• Industry: Chemicals
• Sector: Materials
• Founded: 2007
• Employees: 997
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: EPIGRAL

Financial Performance

In 2023, Epigral's revenue was 19.29 billion, a decrease of -11.84% compared to the previous year's 21.88 billion. Earnings were 1.96 billion, a decrease of -44.56%.